Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 84

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 87
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
Save to Existing Project
Save to a New Project
Anti-microbial Agent Targets in Acanthamoeba
Health Technologies at Strathclyde United Kingdom flag United Kingdom
Abstract ID:
A simple method to make contact lenses safer by eliminating infections by Acanthamoeba....
Email me a copy of this message


Through improper storage, handling, and disinfection of contact lenses, Acanthamoeba, a microscopic amoeba, can enter the eye and cause severe ulcerations of the cornea - a condition called Acanthamoeba keratitis. 
Current treatments are extremely cumbersome and often fail as Acanthamoeba can develop into cysts that are resistant to the drugs used to treat it.  Even if successful, the damage to the eye can be so extensive that a cornea transplant is required. Moreover, the drug-resistant cysts remaining in the eye can re-infect the transplanted cornea.



In order to tackle these problems, researchers at the University of Strathclyde have identified a compound that can effectively treat and prevent the disease. The team have obtained evidence that by inhibiting a biological pathway, it is possible to restrict the growth of the parasite in vitro.

Key Benefits

·         Prevention and treatment of Acanthamoeba keratitis

·         Eliminates risk of re-infection

·         Simple treatment

·         Affordable

Markets and Applications

·         Improved contact lens solutions for prevention of infection

·         Improved drugs for treatment of infection

Type of Business Relationship Sought

sought Contact is welcomed from organisations interested in developing, licensing or exploiting this technology

Last Updated Oct 2013
Technology Type
Phase of Development EARLY STAGE